MEDIF News and Press, Medipharm Labs Corp From 08/15/22

MediPharm Labs Reports Second Quarter Results Canada NewsWire TORONTO , Aug. 15, 2022 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-bas...

MediPharm Labs Sets Date to Report Second Quarter 2022 Financial Results PR Newswire BARRIE, ON , Aug. 11, 2022 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company") a pharmac...

MediPharm Labs Enters Cannabis Research Agreement with Keck School of Medicine of USC Canada NewsWire MediPharm to design, manufacture and supply a liquid oral cannabis study drug for the Phase 2 Life's end Benefits of cannabidiol and tetrahydroca...

MediPharm Labs Awarded Payment of $9.8M in Connection to a 2020 Statement of Claim Against a Previous Customer Canada NewsWire BARRIE, ON , July 27, 2022 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs...

MediPharm Labs ( OTCQX:MEDIF ) entered into a share purchase agreement with OneLife Botanicals for the sale of MediPharm Labs Australia, a wholly-owned subsidiary of the company, for a minimum value of AUD$6.9M. The agreement is subject to routine conditions and is anticipated...

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF ) is selling its MediPharm Labs Australia Pty Ltd to OneLife Botanicals PTY in a deal valued at $6.9M AUD ( $6.2M CAD). The transaction is expected to close within 90 days. The deal includes the assets of MPLA, special...

MediPharm Labs Enters into $6.2M Purchase Agreement for the Sale of Australian Facility Canada NewsWire BARRIE, ON , July 11, 2022 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs" or the "Company") a pharmaceutical company ...

MediPharm Labs Announces Voting Results From the 2022 Annual Meeting of Shareholders Canada NewsWire BARRIE, ON , June 30, 2022 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs" or the "Company") a pharmaceutical com...

MediPharm Labs (OTCQX:MEDIF) Q1 net loss narrowed to -C$7.46M, compared to -C$13.87M in the year ago period. Revenue declined -11.25% Y/Y to C$4.88M. The company said that in Q1 it entered the U.S. pharmaceutical market with the completion of the FDA Drug Master File process for pure natural ...

MediPharm Labs Corporation (MEDIF) Q1 2022 Earnings Conference Call May 16, 2022 8:30 am ET Company Participants David Pidduck - Chief Executive Officer Keith Strachan - President Greg Hunter - Chief Financial Officer Conference Call Participants Shaan Mir - Canaccord Genuity Nick - Roth Capi...